AXSOME THERAPEUTICS, INC. Capital Expenditures
AXSOME THERAPEUTICS, INC. (AXSM) reported Capital Expenditures of $571.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-10
- AXSOME THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $450.00K, a 3361.54% increase year-over-year.
- AXSOME THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $121.00K, a 64.20% decline year-over-year.
- AXSOME THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $71.00K, a 136.67% increase year-over-year.
- AXSOME THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $58.00K, a 35.56% decline year-over-year.
- AXSOME THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $480.00K, a 77.78% increase from fiscal 2024.
- AXSOME THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $270.00K, a 53.61% decline from fiscal 2023.
- AXSOME THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $582.00K, a 17.09% decline from fiscal 2022.
- AXSOME THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $702.00K, a 127.92% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 3 month as first filed | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $450.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $571.00K 10-Q · filed 2026-08-10 | $642.00K derived: sum of 3 quarters · filed 2026-08-10 | $700.00K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | $121.00K 10-Q · filed 2026-05-04 | $192.00K derived: sum of 2 quarters · filed 2026-05-04 | $250.00K derived: sum of 3 quarters · filed 2026-05-04 | $263.00K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | $71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $129.00K derived: sum of 2 quarters · filed 2026-02-23 | $142.00K derived: sum of 3 quarters · filed 2026-08-10 | $480.00K 10-K · filed 2026-02-23 | ||||
| 2025-09-30 | $58.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $71.00K derived: sum of 2 quarters · filed 2026-08-10 | $409.00K 10-Q · filed 2025-11-03 | $439.00K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | $13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $351.00K 10-Q · filed 2026-08-10 | $381.00K derived: sum of 3 quarters · filed 2026-08-10 | $471.00K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | $338.00K 10-Q · filed 2026-05-04 | $368.00K derived: sum of 2 quarters · filed 2026-05-04 | $458.00K derived: sum of 3 quarters · filed 2026-05-04 | $510.00K derived: sum of 4 quarters · filed 2026-05-04 | ||||
| 2024-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $120.00K derived: sum of 2 quarters · filed 2026-02-23 | $172.00K derived: sum of 3 quarters · filed 2026-02-23 | $270.00K 10-K · filed 2026-02-23 | ||||
| 2024-09-30 | $90.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $142.00K derived: sum of 2 quarters · filed 2025-11-03 | $240.00K 10-Q · filed 2025-11-03 | $247.00K derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2024-06-30 | $52.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $150.00K 10-Q · filed 2025-08-04 | $157.00K derived: sum of 3 quarters · filed 2026-02-23 | $528.00K derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2024-03-31 | $98.00K 10-Q · filed 2025-05-05 | $105.00K derived: sum of 2 quarters · filed 2026-02-23 | $476.00K derived: sum of 3 quarters · filed 2026-02-23 | $609.00K derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2023-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $378.00K derived: sum of 2 quarters · filed 2026-02-23 | $511.00K derived: sum of 3 quarters · filed 2026-02-23 | $582.00K 10-K · filed 2026-02-23 | ||||
| 2023-09-30 | $371.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $504.00K derived: sum of 2 quarters · filed 2024-11-12 | $575.00K 10-Q · filed 2024-11-12 | $756.00K derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-06-30 | $133.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $204.00K 10-Q · filed 2024-08-05 | $385.00K derived: sum of 3 quarters · filed 2025-02-18 | $451.00K derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-03-31 | $71.00K 10-Q · filed 2024-05-06 | $252.00K derived: sum of 2 quarters · filed 2025-02-18 | $318.00K derived: sum of 3 quarters · filed 2025-02-18 | $559.00K derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2022-12-31 | $181.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $247.00K derived: sum of 2 quarters · filed 2025-02-18 | $488.00K derived: sum of 3 quarters · filed 2025-02-18 | $702.00K 10-K · filed 2025-02-18 | $702.11K 10-K · filed 2023-02-28 | |||
| 2022-09-30 | $66.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $307.00K derived: sum of 2 quarters · filed 2023-11-06 | $521.00K 10-Q · filed 2023-11-06 | $521.25K 10-Q · filed 2022-11-07 | $521.45K derived: sum of 4 quarters · filed 2024-02-23 | |||
| 2022-06-30 | $241.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $455.00K 10-Q · filed 2023-08-07 | $455.19K 10-Q · filed 2022-08-09 | $455.45K derived: sum of 3 quarters · filed 2024-02-23 | $714.13K derived: sum of 4 quarters · filed 2024-02-23 | |||
| 2022-03-31 | $214.00K 10-Q · filed 2023-05-09 | $213.74K 10-Q · filed 2022-05-02 | $214.45K derived: sum of 2 quarters · filed 2024-02-23 | $473.13K derived: sum of 3 quarters · filed 2024-02-23 | $492.00K derived: sum of 4 quarters · filed 2024-02-23 | |||
| 2021-12-31 | $451.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $259.13K derived: sum of 2 quarters · filed 2024-02-23 | $278.00K derived: sum of 3 quarters · filed 2024-02-23 | $308.00K 10-K · filed 2024-02-23 | $307.55K 10-K · filed 2022-03-01 | |||
| 2021-09-30 | $258.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $277.55K derived: sum of 2 quarters · filed 2022-11-07 | $307.55K 10-Q · filed 2022-11-07 | $327.84K derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | $18.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $48.87K 10-Q · filed 2022-08-09 | $69.16K derived: sum of 3 quarters · filed 2023-02-28 | $84.00K derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | $30.00K 10-Q · filed 2022-05-02 | $50.28K derived: sum of 2 quarters · filed 2023-02-28 | $65.13K derived: sum of 3 quarters · filed 2023-02-28 | $66.56K derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $20.29K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $35.13K derived: sum of 2 quarters · filed 2023-02-28 | $36.56K derived: sum of 3 quarters · filed 2023-02-28 | $45.89K 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $14.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $16.27K derived: sum of 2 quarters · filed 2021-11-08 | $25.60K 10-Q · filed 2021-11-08 | $27.07K derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | $1.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $10.76K 10-Q · filed 2021-08-09 | $12.22K derived: sum of 3 quarters · filed 2022-03-01 | $15.42K derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | $9.33K 10-Q · filed 2021-05-10 | $10.79K derived: sum of 2 quarters · filed 2022-03-01 | $13.99K derived: sum of 3 quarters · filed 2022-03-01 | |||||
| 2019-12-31 | $1.46K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $4.66K derived: sum of 2 quarters · filed 2022-03-01 | $16.12K 10-K · filed 2022-03-01 | |||||
| 2019-09-30 | $3.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $14.66K 10-Q · filed 2020-11-05 | ||||||
| 2019-06-30 | $11.46K 10-Q · filed 2020-08-10 | |||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $8.48K derived: sum of 2 quarters · filed 2021-03-01 | $18.12K derived: sum of 3 quarters · filed 2021-03-01 | $32.70K 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | $8.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $18.12K derived: sum of 2 quarters · filed 2019-11-07 | $32.70K 10-Q · filed 2019-11-07 | $32.70K derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-06-30 | $9.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $24.21K 10-Q · filed 2019-08-08 | $24.22K derived: sum of 3 quarters · filed 2020-03-12 | $27.82K derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-03-31 | $14.58K 10-Q · filed 2019-05-09 | $14.58K derived: sum of 2 quarters · filed 2020-03-12 | $18.18K derived: sum of 3 quarters · filed 2020-03-12 | $21.57K derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2017-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $3.60K derived: sum of 2 quarters · filed 2020-03-12 | $7.00K derived: sum of 3 quarters · filed 2020-03-12 | $9.90K 10-K · filed 2020-03-12 | ||||
| 2017-09-30 | $3.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $7.00K derived: sum of 2 quarters · filed 2018-11-09 | $9.90K 10-Q · filed 2018-11-09 | $15.95K derived: sum of 4 quarters · filed 2019-03-15 | ||||
| 2017-06-30 | $3.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $6.29K 10-Q · filed 2018-08-08 | $12.35K derived: sum of 3 quarters · filed 2019-03-15 | $88.60K derived: sum of 4 quarters · filed 2019-03-15 | ||||
| 2017-03-31 | $2.90K 10-Q · filed 2018-05-08 | $8.95K derived: sum of 2 quarters · filed 2019-03-15 | $85.21K derived: sum of 3 quarters · filed 2019-03-15 | $96.81K derived: sum of 4 quarters · filed 2019-03-15 | ||||
| 2016-12-31 | $6.05K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $82.31K derived: sum of 2 quarters · filed 2019-03-15 | $93.91K derived: sum of 3 quarters · filed 2019-03-15 | $104.56K 10-K · filed 2019-03-15 | ||||
| 2016-09-30 | $76.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $87.86K derived: sum of 2 quarters · filed 2017-11-08 | $98.51K 10-Q · filed 2017-11-08 | $102.62K derived: sum of 4 quarters · filed 2018-03-07 | ||||
| 2016-06-30 | $11.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $22.25K 10-Q · filed 2017-08-09 | $26.36K derived: sum of 3 quarters · filed 2018-03-07 | $30.77K derived: sum of 4 quarters · filed 2018-03-07 | ||||
| 2016-03-31 | $10.65K 10-Q · filed 2017-05-09 | $14.76K derived: sum of 2 quarters · filed 2018-03-07 | $19.17K derived: sum of 3 quarters · filed 2018-03-07 | $20.59K derived: sum of 4 quarters · filed 2018-03-07 | ||||
| 2015-12-31 | $4.11K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $8.52K derived: sum of 2 quarters · filed 2018-03-07 | $9.94K derived: sum of 3 quarters · filed 2018-03-07 | $20.20K 10-K · filed 2018-03-07 | ||||
| 2015-09-30 | $4.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $5.83K derived: sum of 2 quarters · filed 2016-11-14 | $16.08K 10-Q · filed 2016-11-14 | |||||
| 2015-06-30 | $1.42K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2016-08-09 | $11.68K 10-Q · filed 2016-08-09 | ||||||
| 2015-03-31 | $10.26K 10-Q/A · filed 2016-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |